VelosBio doses first patient in Phase II solid tumour drug trial
Biopharmaceutical company VelosBio has dosed the first patient in a Phase II trial of investigational drug VLS-101 in patients with…
Latest News
-
14 hours
-
18 hours
-
18 hours
-
4 days
-
14 hours
-
18 hours
-
18 hours
-
4 days
Chinese Covid-19 vaccine shows promising results in Phase I/II trial
A potential Covid-19 vaccine being developed by China National Biotech Group (CNBG) unit Beijing Institute of Biologic Products demonstrated to…
Latest News
View More
Sanofi and Translate Bio find positive preclinical Covid-19 vaccine results
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results that showed mRNA-based vaccine candidate, MRT5500 induced a favourable immune…
Evelo Biosciences concludes patient enrolment in atopic dermatitis drug trial
Biotech firm Evelo Biosciences has completed enrolment of 24 patients in the Phase Ib EDP1815-101 trial cohort of investigational oral biologic EDP1815 for the treatment…
Astex trials of guadecitabine for leukaemia fail to meet primary end point
Astex Pharmaceuticals has reported that Phase III trials of guadecitabine (sSGI-110) failed to meet the primary endpoint of improving overall…
Bayer’s Aliqopa provides prolonged progression-free survival in iNHL trial
Bayer has reported that the Phase III CHRONOS-3 trial of Aliqopa (copanlisib) in combination with rituximab to treat patients with…
Vaxart begins dosing in trial of oral Covid-19 vaccine candidate
Biotechnology firm Vaxart has started dosing participants in a Phase I clinical trial of oral tablet Covid-19 vaccine candidate, VXA-CoV2-1.…
NIH launches clinical trial for Covid-19 therapies
The US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) has launched the ACTIV-5…
Latest Content
View More
Kyowa Kirin’s Poteligeo provides progression-free survival in CTCL trial
Kyowa Kirin has reported that the MAVORIC trial of Poteligeo (mogamulizumab) in patients with mycosis fungoides (MF) and Sézary syndrome…
Takeda reports positive interim data from trial of Entyvio
Takeda Pharmaceutical has reported positive interim results from the VISIBLE open-label extension (OLE) trial of a subcutaneous formulation of Entyvio…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…
How the Formedix Visual Define.xml Editor Gives You Faster Define
Define.xml is the metadata that describes the content and formatting of submission datasets and the case report tabulation data. It’s…
In Vivo Pharmacology and PK/PD Testing of Novel Therapeutics Webinar
Noble Life Sciences is pleased to announce that it will be hosting In Vivo Pharmacology and PK/PD Testing of Novel…